The group cut a third of its staff, closed international offices, and revamped its governance structure. These efforts appear to be bearing fruit, with major firms returning and participating in the CBI’s regional councils and committees.
AstraZeneca, the UK’s most valuable public company, is now represented on several key CBI committees, including the president’s committee and the taxation committee, after pausing its engagement during the investigation. Unilever and GSK have also resumed active roles, while new members, including JLL and Drax, are rejoining the CBI’s leadership ranks.
Despite the organisation’s progress, leading retailers Tesco and John Lewis have yet to renew their memberships. The CBI remains optimistic about its future, with plans to host a high-profile summer reception in September and publish its annual report in October, highlighting ongoing efforts to rebuild trust and strengthen ties with the new government.
